MIR17HG and gastric cancer: Our study further confirmed that IRF-1 can effectively transcriptionally inhibit the expression of MIR17HG and overcome the promotion of GC metastasis, and these findings underscore the potential clinical relevance of the interactions between IRF-1 and MIR17HG.